IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
NEW DELHI, March 24, 2026 /PRNewswire/ -- According to the latest research report published by MarkNtel Advisors, the Global Plasma Fractionation Market is projected to grow at a CAGR of around 6.15% ...
As the fifth largest plasma-derived therapies manufacturer in the world, Kedrion collects and processes plasma, selecting and purifying proteins of medical interest and developing them into therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results